Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate the superiority of secukinumab 150 mg and/or 300 mg to placebo in subjects with moderate to severe palmoplantar psoriasis as assessed by the palmoplantar Investigator's Global Assessment (ppIGA) at Week 16
Inclusion criteria
- moderate to severe palmoplantar psoriasis